Bicycle Therapeutics plc (BCYC) ADS REP 1 SHS SPON

Sell:$6.69Buy:$6.79Price increased$0.08 (1.21%)

NASDAQ:Price increased0.39%
Market closed |
Prices delayed by at least 15 minutes
Sell:$6.69
Buy:$6.79
Change:Price increased$0.08 (1.21%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$6.69
Buy:$6.79
Change:Price increased$0.08 (1.21%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 January 2026
Kevin LeeCEO
Sell
Tax related
10,989$6.46$70,988.94618,996
5 January 2026
Michael SkynnerCTO
Sell
Tax related
3,266$6.46$21,098.36161,966
5 January 2026
Alistair MilnesCOO
Sell
Tax related
3,416$6.46$22,067.36136,717
5 January 2026
Michael Charles Ferguson (Mike) HannayChief Level Officer
Sell
Tax related
2,367$6.45$15,267.1597,908
5 January 2026
Alethia YoungCFO
Sell
Tax related
2,456$6.45$15,841.2088,959
5 January 2026
Alethia YoungCFO
Sell
Option/Award related
1,878$6.54$12,282.1287,081
5 January 2026
Travis Alvin ThompsonChief Accounting Officer
Sell
Tax related
1,115$6.45$7,191.7566,265
2 January 2026
Kevin LeeCEO
Sell
Tax related
10,325$6.80$70,210.00629,985
2 January 2026
Michael SkynnerCTO
Sell
Tax related
3,045$6.80$20,706.00165,232
2 January 2026
Alistair MilnesCOO
Sell
Tax related
3,244$6.80$22,059.20140,133

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 January 2026
Kevin LeeCEO
Sell
Tax related
10,989$6.46$70,988.94618,996
2 January 2026
Kevin LeeCEO
Sell
Tax related
10,325$6.80$70,210.00629,985
3 October 2025
Kevin LeeCEO
Sell
Tax related
3,231$8.41$27,172.71475,310
3 April 2025
Kevin LeeCEO
Sell
Tax related
3,432$7.48$25,671.36486,265
3 July 2025
Kevin LeeCEO
Sell
Tax related
3,193$7.44$23,755.92480,804

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.